BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Prognosis
6 results:

  • 1. Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.
    Kong W; Tu Y; Jiang P; Huang Y; Zhang J; Jiang S; Li N; Yuan R
    Int J Biol Markers; 2022 Dec; 37(4):395-403. PubMed ID: 36250543
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic significance of tumor budding, poorly differentiated cluster, and desmoplastic reaction in endometrioid endometrial carcinomas.
    Yamamoto M; Kaizaki Y; Kogami A; Hara T; Sakai Y; Tsuchida T
    J Obstet Gynaecol Res; 2021 Nov; 47(11):3958-3967. PubMed ID: 34448279
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical cancer.
    Prabawa IPY; Bhargah A; Liwang F; Tandio DA; Tandio AL; Lestari AAW; Budiana ING; Manuaba IBAP
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):863-868. PubMed ID: 30912405
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
    Stelloo E; Bosse T; Nout RA; MacKay HJ; Church DN; Nijman HW; Leary A; Edmondson RJ; Powell ME; Crosbie EJ; Kitchener HC; Mileshkin L; Pollock PM; Smit VT; Creutzberg CL
    Mod Pathol; 2015 Jun; 28(6):836-44. PubMed ID: 25720322
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mutant p53 protein in the serum of patients with cervical carcinoma: correlation with the level of serum epidermal growth factor receptor and prognostic significance.
    Oh MJ; Choi JH; Lee YH; Lee JK; Hur JY; Park YK; Lee KW; Chough SY; Saw HS
    Cancer Lett; 2004 Jan; 203(1):107-12. PubMed ID: 14670624
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.